David J Diemert

22PUBLICATIONS
220CO-AUTHORS
Predictive and prognostic markersInnate immunityMedical molecular engineering of nucleic acids and proteinsVenereologyCommunication technology and digital media studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 04, 2026
Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants.

|May 07, 2026
Influenza A and B Viral Shedding in Adults Immunized With Live Attenuated Influenza Vaccine.

|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humans.

Tom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski

|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.

Jordan R Willis, Madhu Prabhakaran, Michelle Muthui

|Jan 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Bo Zhang, Youyi Fong, Lauren Dang

|Jan 08, 2025
Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.

David J Diemert, Maria Zumer, Mark Bova

Pageof 4

Frequent Collaborators

5 joint publications

Adrian B McDermott

4 joint publications

M Juliana McElrath

4 joint publications

Daniel S Graciaa

4 joint publications

Allan C deCamp